Association of clinicopathological variables with MHC-I and pSer616 DRP-1 expression levels, as well as univariate and multivariate analysis of variables associated with overall survival (OS) of these cancer patients, is shown in Supplementary Tables 1 and 2. This evidence concerns the gene DNM1L and cancer.